| Literature DB >> 29324667 |
Stefanie Staats1, Anika E Wagner2, Bianca Kowalewski3, Florian T Rieck4, Sebastian T Soukup5, Sabine E Kulling6, Gerald Rimbach7.
Abstract
In this study, we tested the effect of the stilbene resveratrol on life span, body composition, locomotor activity, stress response, and the expression of genes encoding proteins centrally involved in ageing pathways in the model organism Drosophila melanogaster. Male and female w1118 D. melanogaster were fed diets based on sucrose, corn meal, and yeast. Flies either received a control diet or a diet supplemented with 500 µmol/L resveratrol. Dietary resveratrol did not affect mean, median, and maximal life span of male and female flies. Furthermore, body composition remained largely unchanged following the resveratrol supplementation. Locomotor activity, as determined by the climbing index, was not significantly different between control and resveratrol-supplemented flies. Resveratrol-fed flies did not exhibit an improved stress response towards hydrogen peroxide as compared to controls. Resveratrol did not change mRNA steady levels of antioxidant (catalase, glutathione-S-transferase, NADH dehydrogenase, glutathione peroxidase, superoxide dismutase 2) and longevity-related genes, including sirtuin 2, spargel, and I'm Not Dead Yet. Collectively, present data suggest that resveratrol does not affect life span, body composition, locomotor activity, stress response, and longevity-associated gene expression in w1118 D. melanogaster.Entities:
Keywords: Drosophila; healthy ageing; life span; longevity; resveratrol
Mesh:
Substances:
Year: 2018 PMID: 29324667 PMCID: PMC5796172 DOI: 10.3390/ijms19010223
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Dietary resveratrol (RESV; 500 µmol/L) does not affect feed intake in w. (a) Relative feed intake in male and female flies following a five-day feeding period with a RESV-supplemented or a control diet. Flies were administered the experimental diets for five days prior to administration of a sulforhodamine B (0.2% w/v)-supplemented medium for 8 h. Feed intake was quantified via fluorometric measurements. Feed intake of RESV-treated males and females was normalised to the feed intake of their control fed counterparts, respectively. Bars show means ± SEM comprising 60–100 flies/group. Statistics: 2-sided Student’s t-test and Mann–Whitney U.; (b) Bright-field pictures of male and female w flies administered with sulforhodamine B for 8 h. Arrows point to pink-coloured body parts due to the sulforhodamine B ingestion.
Changes in body weight and body composition of male and female w in dependence of dietary resveratrol (RESV; 500 µmol/L) administration for ten days compared to controls.
| Parameter | Male | Female | ||||
|---|---|---|---|---|---|---|
| Control | RESV 1 | Control | RESV 1 | |||
| Body weight (µg/fly) | 778 ± 46 | 774 ± 42 | 0.953 | 1222 ± 43 | 1223 ± 77 | 0.989 |
| Triglycerides (% control) | 100 ± 9.0 | 165 ± 31 | 0.083 | 100 ± 5.1 | 95.5 ± 13 | 0.750 |
| Protein (% control) | 100 ± 1.8 | 121 ± 7.5 | 100 ± 2.0 | 103 ± 5.3 | 0.679 | |
| Glucose (% control) | 100 ± 12 | 115 ± 21 | 0.500 | 100 ± 14 | 156 ± 34 | 0.100 |
All data are shown as means ± SEM from three independent experiments comprising 178–224 flies/group (body weight) and 20–35 flies/group (body composition). Outliers were removed. Statistics: 2-sided Student’s t-test and Mann–Whitney U. 1 RESV: resveratrol (500 µmol/L).
Figure 2Dietary resveratrol (RESV; 500 µmol/L) does not affect locomotor activity in w. Relative climbing activity of male and female flies following a thirty-day feeding period in the presence or absence of resveratrol. Locomotor activity was quantified via the rapid iterative negative geotaxis (RING) assay. Bars show means ± SEM from 20 measurements/group derived from two independent experiments. Statistics: Mann–Whitney U. RESV: resveratrol (500 µmol/L).
Figure 3Dietary resveratrol (RESV; 500 µmol/L) does not improve stress resistance of w against reactive oxygen species. Flies received a resveratrol-supplemented or a control diet for ten days prior to the exposure to hydrogen peroxide (10% w/v diluted in a 5% w/v sucrose solution). Dead flies were steadily counted every four hours. (a) Survival curve of male and (b) female flies. The stress resistance experiment was independently performed three times with 45 flies/group each revealing similar results. Statistics: Log-Rank.
Relative mRNA expression of antioxidant enzymes in female w in dependence of resveratrol (RESV; 500 µmol/L) administration for ten days compared to controls.
| Target | mRNA Expression | |
|---|---|---|
| 0.87 ± 0.15 | 0.700 | |
| 1.02 ± 0.22 | 0.948 | |
| 0.99 ± 0.22 | 0.963 | |
| 0.89 ± 0.17 | 0.741 | |
| 1.03 ± 0.18 | 0.930 |
Data are shown as means ± SEM comprising 40 flies/group from two independent experiments; α-Tubulin at 84B (αTub84B) and Ribosomal protein L32 (RpL32) served as the housekeeping genes. Statistics: 2-sided Student’s t-test and Mann–Whitney U. 1 Cat: Catalase; 2 GstD2: Glutathione S transferase D2; 3 ND-75: NADH dehydrogenase (ubiquinone) 75 kDa subunit; 4 PHGPx: PHGPx with glutathione peroxidase activity; 5 Sod2: Superoxide dismutase 2 (Mn). 6 p-value indicates differences in relative mRNA expression in whole body RNA extracts of resveratrol treated flies compared to controls.
Differences in mean, median, and maximum survival rates (%) of male and female w in dependence of life-long dietary resveratrol (RESV; 500 µmol/L) administration compared to controls.
| Trial | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean | Median | Max. 1 | Mean | Median | Max. 1 | |||
| No. 1 | +15.2 | +2.50 | +1.03 | 0.307 | −8.20 | −7.50 | −14.1 | 0.066 |
| No. 2 | −11.8 | −19.6 | +3.04 | 0.345 | −14.7 | −46.2 | −1.04 | 0.099 |
| No. 3 | −33.1 | −56.3 | −9.35 | <0.001 | +15.9 | ±0.00 | +1.06 | 0.341 |
The life span experiment was independently performed three times (Trial No. 1–3) comprising 150 flies/group in each experiment. Changes in mean, medium, and maximum life span (% control) of RESV treated males and females in comparison to the respective control group are shown for each single experiment. RESV did not improve the life span of male and female w. Statistics: Log-Rank. RESV: resveratrol (500 µmol/L); data are shown as means. 1 max.: maximum lifespan defined as the mean survival of the longest-lived 10%; 2 p-value indicates differences in overall survival benefit of resveratrol treated flies compared to controls.
Relative mRNA expression of longevity-associated genes in male and female w in dependence of resveratrol (RESV; 500 µmol/L) administration for ten days compared to controls.
| Sex | Transcript | |||||
|---|---|---|---|---|---|---|
| Male | 0.90 ± 0.19 | 0.700 | 1.13 ± 0.15 | 0.437 | 1.77 ± 0.74 | 0.375 |
| Female | 0.83 ± 0.12 | 0.405 | 1.02 ± 0.14 | 0.913 | 1.12 ± 0.19 | 0.593 |
Data are shown as means ± SEM comprising 40 flies/group in total from two independent experiments; α-Tubulin at 84B (αTub84B) and Ribosomal protein L32 (RpL32) served as the housekeeping genes. Statistics: 2-sided Student’s t-test and Mann–Whitney U. 1 Sir2: Sirtuin 2; 2 INDY: I’m Not Dead Yet; 3 srl: spargel; 4 p-value indicates differences in relative mRNA expression in whole body RNA extracts of resveratrol-treated flies compared to controls.